Catalogo Articoli (Spogli Riviste)

OPAC HELP

Titolo:
INTRAARTERIAL UROKINASE VERSUS SURGERY FOR ACUTE PERIPHERAL ARTERIAL-OCCLUSION
Autore:
NEUDECK BL; BLUMENSCHEIN K; ENDEAN ED; LOH FK; RAPP RP;
Indirizzi:
UNIV KENTUCKY,ALBERT B CHANDLER MED CTR,DEPT PHARM,DIV PHARM PRACTICE& SCI,800 ROSE ST LEXINGTON KY 40536 UNIV KENTUCKY,ALBERT B CHANDLER MED CTR,DEPT PHARM,DIV PHARM PRACTICE& SCI LEXINGTON KY 40536 UNIV KENTUCKY,MED CTR,DEPT SURG,DIV GEN SURG LEXINGTON KY 40506 UNIV KENTUCKY,MED CTR,DEPT DIAGNOST RADIOL LEXINGTON KY 40506
Titolo Testata:
American journal of health-system pharmacy
fascicolo: 17, volume: 54, anno: 1997,
pagine: 1963 - 1968
SICI:
1079-2082(1997)54:17<1963:IUVSFA>2.0.ZU;2-3
Fonte:
ISI
Lingua:
ENG
Soggetto:
THROMBOLYTIC THERAPY; LOCAL THROMBOLYSIS; GRAFT OCCLUSIONS; BYPASS GRAFTS; STREPTOKINASE;
Keywords:
ARTERIAL OCCLUSIVE DISEASES; COSTS; DRUG COMPARISONS; HOSPITALS; INFECTIONS; MORTALITY; SURGERY; THROMBOLYTIC AGENTS; UROKINASE;
Tipo documento:
Article
Natura:
Periodico
Settore Disciplinare:
Science Citation Index Expanded
Citazioni:
17
Recensione:
Indirizzi per estratti:
Citazione:
B.L. Neudeck et al., "INTRAARTERIAL UROKINASE VERSUS SURGERY FOR ACUTE PERIPHERAL ARTERIAL-OCCLUSION", American journal of health-system pharmacy, 54(17), 1997, pp. 1963-1968

Abstract

The outcomes of intra-arterial urokinase versus surgery for acute peripheral arterial occlusion (PAO) were compared. Patients at a university hospital who had received intraarterial urokinase for PAO were identified by computer and pair-matched on the basis of comorbidities, age, sex, and site of occlusion to computer-selected patients who had undergone surgery. Only patients with category I or II ischemia were considered. The study period for the urokinase group was February 1995 through January 1996, and the period for the surgery group was June 1993 through January 1996. Twenty-eight patients in each group met the selection criteria. Patients who had received urokinase had a significantly shorter median length of stay (8.5 days) than patients in the surgery group (13 days) and significantly fewer infectious complications (2 versus 10). No differences in amputation rates, total hospital costs, or mortality rates were detected. Patients who received intra-arterialurokinase for PAO had a shorter length of stay in the hospital and fewer infectious complications than those who underwent surgery.

ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 25/11/20 alle ore 01:25:06